Trio of new medicines originate from Scripps Research discoveries
March 26, 2019
La Jolla, CA - While billions of investment dollars pour into pharmaceutical development in the biotechnology and pharmaceutical industry sector each year, centers of academic excellence remain the birthplace of innovative discoveries that enable novel treatment strategies addressing the world's most dire unmet medical needs.
Scripps Research is doubling down on its legacy of discovery biology that is translated into much-needed new medicines within the boundaries of Scripps Research, a track-record exemplified by a trio of new drugs making their way to the marketplace.
The pharmaceutical company Celgene announced Monday that it filed an application with the U.S. Food and Drug Administration seeking approval to treat multiple sclerosis (MS) with ozanimod, a drug invented by Scripps Research professors Hugh Rosen, MD, PhD, and Edward Roberts, PhD.
In January, the FDA also accepted a drug application from Pfizer for the treatment of cardiomyopathy with tafamidis, a medicine invented by Scripps Research professors Jeffery Kelly, PhD, and Evan Powers, PhD. And in May of last year, individuals with a rare genetic disorder called phenylketonuria (PKU) received new hope with the FDA's approval of BioMarin's drug Palynziq , which was developed in collaboration with the Scripps Research laboratory of Raymond Stevens, PhD.
These three new drugs continue a long history of translating groundbreaking discoveries made at Scripps Research into new drugs used in the clinic, said Matt Tremblay, PhD, chief operating officer of Scripps Research and its drug discovery division, Calibr. They underscore the ability of our researchers to play a major role in creating new medicines.
Scripps Research has originated a total of nine approved drugs, from surfaxin, which helps premature babies take their first breaths, to humira, an inflammation-blocking antibody used to treat rheumatoid arthritis and other conditions.
Over the past two years, Scripps Research has greatly expanded its own in-house translational research capacity with the aim of advancing its medicines through clinical studies in patients and reinvesting revenues from those drugs back into research. Under the leadership of Peter Schultz, PhD, president and CEO, the institute has assembled a unique infrastructure by merging with two other entities: Calibr, a nonprofit drug discovery center with a pipeline of new medicines founded by Schultz in 2012; and the Scripps Research Translational Institute, founded by Eric Topol, MD, that focuses on personalizing medicine with the power of genomics, wireless digital technologies and artificial intelligence.
This new business model for nonprofit research institutes simultaneously fuels fundamental biomedical discoveries and speeds their translation into medicines by re-investing licensing revenues into ongoing basic and translational science. Ozanimod, tafamidis and Palynziq demonstrate how scientific insight into the biology underlying disorders are essential to developing therapies, and how that insight can be effectively paired with drug development expertise to have a significant impact on patients living with disease.
The seminal discovery that led to ozanimod was reported by Rosen and his team in Science in 2002. They showed that altering the activity of certain cellular receptors could dampen the effects of the immune system. Working with Roberts and other researchers, Rosen developed ozanimod, which binds to these receptors and inactivates immune system cells involved in MS and inflammatory bowel disease (IBD).
Celgene acquired the rights to ozanimod in 2015 and the application filing announced this week seeks approval to market the drug for relapsing and relapsing-remitting MS. At the same time, Phase 3 studies for ulcerative colitis, a form of IBD, are on track to be completed by mid-2020, resulting in a subsequent filing for approval in 2021.
The story of ozanimod and these other new therapies highlights the uniqueness of Scripps Research, Rosen says. There are hardly any other academic institutions in the world that have the multidisciplinary expertise to discover a new disease-modifying compound and generate clinical data in support of its development.
Tafamidis, conceived and synthesized in Kelly's lab and now exclusively licensed to Pfizer, has been approved in 40 countries for the treatment of familial amyloid polyneuropathy (FAP), a rare neurodegenerative disorder that results from transthyretin aggregation. Pfizer has also recently completed a tafamidis Phase 3 clinical trial in individuals with the heart disorder transthyretin amyloid cardiomyopathy, which affects a much larger population. Tafamidis demonstrated a significant reduction in the risk of all-cause mortality and cardiovascular-related hospitalizations. The FDA has granted fast track designation for considering approval of tafamidis for this condition, which leads to congestive heart failure and death within about five years of diagnosis if untreated.
The approval of Palynziq marked a watershed moment for people with PKU, a disorder that occurs in 1 in 10,000 to 15,000 births in the United States.
The therapy replaces a critical enzyme, phenylalanine hydroxylase (PAH), which breaks down phenylalanine, an amino acid found in most proteins and in ubiquitous artificial sweeteners resulting in significant dietary restrictions and life-threatening consequences for PKU patients, who lack the enzyme.
Stevens' research on the three-dimensional structure of the PAH enzyme alone or bound to drug candidates enabled a collaboration with BioMarin that ultimately led to Kuvan , the standard of care for mild PKU patients. By activating the metabolism of phenylalanine, Kuvan expands dietary options for about 40 percent of
Most recent headlines
06/10/2025
France T l visions, France's leading broadcaster, has received the 2025 EBU ...
04/09/2025
Monumental Sports & Entertainment (MSE), in collaboration with Dalet, has been a...
30/08/2025
WASHINGTON The Federal Communications Commission has adopted its FY 2025 Regulatory Fees Order that establishes the regulatory fee rates for the broadcast stati...
29/08/2025
Australian Red Cross and SBS launch training to help workplaces in the fight aga...
29/08/2025
The National Film and Video Foundation (NFVF), an agency of the Department of Sp...
29/08/2025
L3Harris Technologies has concentrated decades of expertise across the entire enterprise to develop affordable and reliable best-of-breed solutions to rapidly c...
29/08/2025
BURBANK, Calif. The CW Network and the Pac-12 Conference have announced a new media rights deal that will extend their broadcast partnership beginning with the ...
29/08/2025
NEW YORK Gracenote has released a new analysis of its global video dataset showing that the number of FAST channels grew nearly 14% from Q1 2025 and 76% since 2...
29/08/2025
SAN JOSE, Calif. Harmonic has announced a series of improvements to its live sports streaming solution that the company said will improve fan engagement, protec...
29/08/2025
NEW YORK and LOS ANGELES Fox Corp. and YouTube TV last night announced a renewal of the full portfolio of Fox networks, including Fox News Channel, Fox Business...
29/08/2025
Budapest, Hungary, August 2025 - The integration of Microsoft Teams Rooms (MTR) with Lightware's Taurus universal matrix switchers delivers a new level of f...
29/08/2025
Frequency, the engine behind many of the world's best-known streaming television channels, today announced it will launch Studio Live, a next-generation uni...
29/08/2025
In an era when AI and cyber resilience are essential, Scality will mark the 10th anniversary of Scality Day on October 16, 2025 in Paris. This flagship global e...
29/08/2025
Disguise's In-House Creative and Technical Teams Pre-Visualised, Programmed and Delivered Content for the Experience, All Powered by EX 3+
Technology solu...
29/08/2025
Disguise will be demonstrating the latest workflows for TV, film and live events on a number of partner booths at the show
Disguise, the industry-leading tech...
29/08/2025
STOCKHOLM, Sweden Accedo will showcase Accedo Compose, its AI agent-powered modular orchestration layer that assists streaming providers in transitioning client...
29/08/2025
LOS ANGELES Cineverse has announced that it is working with Xperi to bring four of its streaming channels to automobiles for the first time as part of the DTS A...
29/08/2025
DALLAS & ATLANTA Gray Media has announced an agreement with the sports streaming service Victory+ to simulcast 17 Dallas Stars NHL games in 15 television market...
29/08/2025
NEW YORK AND CULVER CITY Comcast NBCUniversal and Amazon have announced new and extended distribution agreements that will expand the content available on their...
29/08/2025
FOOTHILL RANCH, Calif. RED Digital Cinema will feature its Cine-Broadcast Module supporting live broadcast workflows during IBC2025, Sept. 12-15, at the RAI Ams...
29/08/2025
29 Aug 2025
Kyivstar Rings Opening Bell at Nasdaq Marking Landmark Listing and ...
29/08/2025
More than half of all NFL games live on Sky for the first timeFriday 29 August 2025
Sky Sports has announced a new three-year deal with the NFL, extending its ...
29/08/2025
Back to All News
RIV4LRIES: The Trailer of the New Series With Samuele Carrino ...
29/08/2025
Get ready for an inspiring and emotional insight into the world of competitive Irish dancing with My Story: Tomi Champion of the World airing on RT 2 this monda...
29/08/2025
RT has today announced that David McCullagh is to be the new presenter of RT Radio 1's flagship Today programme, which airs every weekday at 10am, replaci...
28/08/2025
By Kristin Feeley, Director, Documentary Film & Artist Programs
If you want to tell untold stories, if you want to give voice to the voiceless, you've got ...
28/08/2025
Directed by Steven Bognar and Julia Reichert, Sundance Institute-supported Amer...
28/08/2025
Corridos have been a cornerstone of M sica Mexicana for generations, telling stories rooted in everyday life. Now, a new chapter is taking shape: motivational c...
28/08/2025
Los corridos han sido un pilar de la M sica Mexicana durante generaciones, contando historias enraizadas en la vida cotidiana. Ahora, un nuevo cap tulo est tom...
28/08/2025
Earlier this month, we promised our Verano Forever party would bring the heat, a...
28/08/2025
L3Harris will provide the Polish F-16V fleet with the Viper Shield electronic warfare system as part of an upgrade program....
28/08/2025
Bilbao, August 26, 2025 - AgileTV, an international television and video technol...
28/08/2025
Ken Wilkinson is an Emmy Awards nominated New York audio engineer who specialises in production sound mixing for film, commercial, episodic and documentary work...
28/08/2025
NEW YORK FuboTV today announced that it will launch Fubo Sports, a skinny bundle that focuses on sports with a subscription price of $56 monthly....
28/08/2025
NEVADA City, Calif. At IBC2025, Sept. 12-15 at the RAI Amsterdam, Telestream will debut its new Global Ingest strategy, introducing a next-generation ingest arc...
28/08/2025
Dr. Rhoda Bernard Releases Groundbreaking Debut Book on Accessible Arts Educatio...
28/08/2025
TAG Video Systems, the leader in software-based IP end-to-end workflow monitoring, deep probing, and real-time visualization, has named Oliver Gappa as Sales Di...
28/08/2025
AI-based voice enhancement will be among a series of innovations making their IBC 2025 debut on the DHD stand B46 in Hall 8 at the RAI Amsterdam Convention Cent...
28/08/2025
Telef nica Servicios Audiovisuales (TSA), the leading system integrator and service provider in the media sector in Spain, with the support of Appear, the globa...
28/08/2025
To fully immerse sailing fans in the world's biggest offshore yacht race, production company, Optical Media turned to LiveU's On-site Production solutio...
28/08/2025
Working with Calrec on its most recent overhaul, radio and television broadcaster, WNED has migrated to a fully IP infrastructure with multiple Type R consoles,...
28/08/2025
Cleeng, the Subscriber Retention Management (SRM ) inventor, has unveiled Cleeng Pro, the first-ever direct-to-consumer (D2C) subscription management platform t...
28/08/2025
Zixi, the industry leader in live broadcast-quality video over IP, today announced that French media distribution platform OKAST has selected Zixi to enable rel...
28/08/2025
Solution offers a streamlined, speaker-free architecture to optimize integration with premium external loudspeakers and advanced loudness metering
Nixer Pro Au...
28/08/2025
Cinegy, the premier provider of software-defined television technology, has announced a strategic partnership with Vision One Touch Film Production Services L.L...
28/08/2025
Telestream, a global leader in media workflow technologies, will debut its new Global Ingest strategy at IBC2025, introducing a next-generation ingest architect...
28/08/2025
Tier 1 operator selects Broadpeak to power high-performance, unified CDN solution across Norway, Sweden and Finland
Broadpeak, a leader in streaming and moneti...
28/08/2025
Leading video software provider, Synamedia, today announced that 24 Frames Digital, one of India's leading live event streaming service providers, has chose...
28/08/2025
Meet VisualOn at IBC2025: See What's Next in AI-Powered Video Streaming Join VisualOn at IBC2025 and discover how our AI-driven Optimizer and advanced media...
Trio of new medicines originate from Scripps Research discoveries 
